2005 was a year in which some of Big Pharma’s clandestine relationships with an army of bought-and- paid- for minions in academia,
government, congress, the media, and front organizations were uncovered–in courtrooms, investigative books, reports and films.
Two studies purporting to report “new encouraging” findings about the efficacy and safety of antidepressants—as tested in the “real world”—were published on Sunday by The American Journal of Psychiatry with an accompanying editorial by Dr. Thomas Insel, director of these studies’ funding agency, the National Institute of Mental Health.
Slide 2: I’ll begin with the President’s New Freedom Commission on Mental Health[1] recommendation to screen the US population for mental illness – 52 million children first. In no other democratic country has the government adopted a policy to screen the population for presumed, undetected, mental illness. The rationale behind this mind-boggling Orwellian nightmare is not improving mental health, but rather increasing life-long consumers of psychoactive drugs and to control behavior. Two NFC recommendations are designed to do just that. TeenScreen is promoted as a suicide prevention model when it in fact, increases the number of children labeled suicidal and depressed.
The Columbia lecture was originally scheduled as a debate between David Healy, MD and James Coyne, PhD. The debate did not take place, and Dr. Coyne subsequently lectured in Rutgers the following week. The lecture covered the main points Dr. Coyne makes in the e-mail below. Dr. Healy’s response follows….
Loss of Trust: Big Drug Makers See Sales Decline With Their Image – NYT Mon, 14 Nov 2005 The lead front page article in today’s New York Times reports: “A poll last month showed that only 9 percent of Americans believed drug companies were generally honest, down from 14 percent…
"Every year, drug companies spend $14 billion to test experimental substances on humans. Across the U.S., the centers that do the testing–and the regulators who watch them–allow scores of human test subjects to be injured or killed."
October 14, 2005 link to pdf of original letter Dr. Russell Katz Director, Neuropharmacological Drug Products Food and Drug Administration, FDA 120 1451 Rockville Pike, Room 4037 Rockville, MD 20852 Re: FDA Neurontin Safety Analyses Dear Dr. Katz: Due to the continued public danger facing a substantial class of…
Tom Cruise re-ignited the debate about psychiatry–its false claims & drug hazards – Florida Medicaid restricts Fri, 01 Jul 2005 Tom Cruise “kicked off a debate over a subject that a lot of people don’t feel comfortable discussing: whether Americans are too quick to turn to prescription drugs and whether…
http://www.nytimes.com/2005/06/10/business/10drug.html?ei=5094&en=5475b3c17e50e692&hp =&ex=1118462400&partner=homepage&pagewanted=print THE NEW YORK TIMES June 10, 2005, front page Lucrative Drug, Danger Signals and the F.D.A. By GARDINER HARRIS and ERIC KOLI Dozens had died and more than 100 patients had suffered serious heart problems by March 1998 after taking Propulsid, a popular medicine for heartburn. Infants, given…
TeenScreen: the Law Suits Begin Mon, 13 Jun 2005 Newsworthy developments about the duo-drug promotion scam‹TeenScreen & TMAP: A. The first legal challenge against TeenScreen, the mental health screening scheme that is invading the public school system across the nation, declaring otherwise normal children to be mentally ill, has been…
Grassley Pushes FDA: Transparency, Accountability & Independence / Whistleblowers are essential Witnesses Wed, 8 Jun 2005 The FDA has once again demonstrated bad faith when it appointed an industry biased panel to monitor drug safety. The Washington Post reports that FDA safety officer Dr. David Graham, who blew the whistle…
60 Minutes: Insider’s Rx for Drug Costs – Peter Rost Hits a Homer! Mon, 6 Jun 2005 Dr. Peter Rost, vice-president of marketing, Pfizer Corp., has blown the lid off the pharmaceutical industry and its misrepresentation of why the American taxpayer is being fleeced by drug companies who charge the…
